Differential diagnosis of mature T-cell leukemias by immunophenotype
Immunophenotype . | T-PLL . | T-LGL . | SS . | ATLL . |
---|---|---|---|---|
CD2 | + | + | + | + |
CD3 | + | + | + | ± |
CD7 | + | ± | ± | − |
(strong) | ||||
CD4 | + | − | + | + |
(in 60%) | (rarely +) | (most) | (most) | |
CD8 | + | + | Rare | Rare |
(15%) | ||||
CD4/CD8 coexpression | + (25%) | Rare | Rare | Rare |
Other antigen expression | CD 57/CD16 (often) | CD25 in most cases |
Immunophenotype . | T-PLL . | T-LGL . | SS . | ATLL . |
---|---|---|---|---|
CD2 | + | + | + | + |
CD3 | + | + | + | ± |
CD7 | + | ± | ± | − |
(strong) | ||||
CD4 | + | − | + | + |
(in 60%) | (rarely +) | (most) | (most) | |
CD8 | + | + | Rare | Rare |
(15%) | ||||
CD4/CD8 coexpression | + (25%) | Rare | Rare | Rare |
Other antigen expression | CD 57/CD16 (often) | CD25 in most cases |
T-PLL indicates T-cell prolymphocytic leukemia; T-LGL, T-large granular lymphocytic leukemia; SS, Sezary syndrome; and ATLL, adult T-cell leukemia lymphoma.